Article Per Year (5 Year)
p-Index From 2020 - 2025
0.778
P-Index
This Author published in this journals
All Journal Journal of the Community Development in Asia
Rajesh Kumar Nair
SIES School of Business Studies
Humanities

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Journal of the Community Development in Asia

 1 
Analysis of Strategies Implemented by AirAsia to Cater to the Covid-19 Effects Rajesh Kumar Nair; Varsha Ganatra; Karishma Kaur; Daisy Mui Hung Kee; Wan Teng Khoo; Shi Ying Khor; Keshaav Rao; Janhvi Mahajan
Journal of the Community Development in Asia (JCDA) Vol 4, No 3 (2021): Journal of The Community Development in Asia (JCDA)
Publisher : AIBPM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (338.888 KB) | DOI: 10.32535/jcda.v4i3.1181

Abstract

During the global pandemic, AirAsia reported an annual loss of RM5.9 billion ($1.4 billion) in 2020. The uncertainty of the COVID-19 outbreak, travel restrictions, and border controls had led to weaker air travel demand, which had impacted AirAsia’s operation badly. This paper depicts how Covid-19 impacted AirAsia and the strategies implemented by AirAsia during the pandemic in the marketing aspects. This paper also focuses on how AirAsia can anticipate a strong recovery in the airline industry while expanding to other industries. In extreme and under pressure circumstances, AirAsia implemented many strategies to cater to the effects of Covid-19. However, other strategies, such as focusing on their business in the food industry, should be expanded throughout Malaysia.
A Study to Understand Parents' Perceptions and Societal Attitudes on Bharat Biotech’s Covaxin for Children Ishu Sharma; Akanksha Nadkarni; Sonali Kudale; Shubham Shetye; Rajesh Kumar Nair; Modhi Aljuaid; Majdi Quttainah; Liem Gai Sin
Journal of the Community Development in Asia (JCDA) Vol 5, No 3 (2022): Journal of the Community Development in Asia (JCDA)
Publisher : AIBPM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (332.766 KB) | DOI: 10.32535/jcda.v5i3.1869

Abstract

The recent COVID-19 pandemic has reshaped the perceptions of vaccines worldwide. Presently, vaccines are the most efficacious resource that holds the strength to reduce the risk of the disease. In contrast, public health authorities are concerned about vaccine apprehension among the general public. The distribution and consumption of these vaccines began by segregating the age groups. The eligibility of Covaxin vaccines manufactured by Bharat Biotech for children over 12 years of age makes it critical to investigate its credibility among the parents and public views regarding children receiving these vaccines. Moreover, limited information on public acceptability and trustable opinions contribute to vaccine hesitancy among parents. Consequently, the major deciding factors are getting accurate data about the Covaxin’s clinical trial by Bharat Biotech, the persistence and nature of the child's immune response, and reassurance from society. This research study aims to learn more about parents' perspectives and societal attitudes towards immunity building in children by the Covaxin vaccines. The methodology adopted here leads to a precise understanding if there is any ambiguity or acceptance towards Covaxin for children in the minds of the general public. KeywordsBharat Biotech, Children, Clinical Trial, Covaxin, COVID-19, Immunity, Perception.
Co-Authors Akanksha Nadkarni Daisy Mui Hung Kee Ishu Sharma Janhvi Mahajan Karishma Kaur Keshaav Rao Liem Gai Sin Majdi Quttainah Modhi Aljuaid Ranjith P.V Shazwanie Amat Sazali Shi Ying Khor Shopanadevi Munusamy Shubham Shetye Siti Hajar Azlan Siti Nadiah Rahmat Sonali Kudale Tejashree Ingole Varsha Ganatra Wan Teng Khoo